Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 153

1.

[Hyperbaric oxygen and radiotherapy: From myth to reality].

Espenel S, Raffoux C, Vallard A, Garcia MA, Guy JB, Rancoule C, Ben Mrad M, Langrand-Escure J, Trone JC, Pigne G, Diao P, Magné N.

Cancer Radiother. 2016 Jul;20(5):416-21. doi: 10.1016/j.canrad.2016.04.003. Epub 2016 Jun 21. Review. French.

PMID:
27342943
2.

Biological and Genetic Aspects of Donor-Recipient Matching in HSCT.

Lange A, Raffoux C, Shaw B.

Bone Marrow Res. 2012;2012:212593. doi: 10.1155/2012/212593. Epub 2012 Dec 9. No abstract available.

3.

Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study.

Fleischhauer K, Shaw BE, Gooley T, Malkki M, Bardy P, Bignon JD, Dubois V, Horowitz MM, Madrigal JA, Morishima Y, Oudshoorn M, Ringden O, Spellman S, Velardi A, Zino E, Petersdorf EW; International Histocompatibility Working Group in Hematopoietic Cell Transplantation.

Lancet Oncol. 2012 Apr;13(4):366-74. doi: 10.1016/S1470-2045(12)70004-9. Epub 2012 Feb 15. Erratum in: Lancet Oncol. 2012 Apr;13(4):e134-5.

4.

Does high-resolution donor typing of HLA-C or other loci upon registration confer advantages to patients?

Dubois V, Giannoli C, Balère ML, Rey S, Raffoux C, Rigal D.

Hum Immunol. 2011 Nov;72(11):1033-8. doi: 10.1016/j.humimm.2011.08.007. Epub 2011 Aug 10.

PMID:
21871938
5.

Collaboration between hematopoietic stem cell donor registry and cord blood banks.

Raffoux C.

Transplant Proc. 2010 Oct;42(8):3258-9. doi: 10.1016/j.transproceed.2010.07.032.

PMID:
20970667
6.

Antithymocyte globulins and chronic graft-vs-host disease after myeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors: a report from the Sociéte Française de Greffe de Moelle et de Thérapie Cellulaire.

Mohty M, Labopin M, Balère ML, Socié G, Milpied N, Tabrizi R, Ifrah N, Hicheri Y, Dhedin N, Michallet M, Buzyn A, Cahn JY, Bourhis JH, Blaise D, Raffoux C, Espérou H, Yakoub-Agha I.

Leukemia. 2010 Nov;24(11):1867-74. doi: 10.1038/leu.2010.200. Epub 2010 Sep 30.

PMID:
20882046
7.

Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation.

Gagne K, Busson M, Bignon JD, Balère-Appert ML, Loiseau P, Dormoy A, Dubois V, Perrier P, Jollet I, Bois M, Masson D, Moine A, Absi L, Blaise D, Charron D, Raffoux C; ARS2000 FRM and FGM group.

Biol Blood Marrow Transplant. 2009 Nov;15(11):1366-75. doi: 10.1016/j.bbmt.2009.06.015.

8.

Association of HLA-A in autoimmune myasthenia gravis with thymoma.

Vandiedonck C, Raffoux C, Eymard B, Tranchant C, Dulmet E, Krumeich S, Gajdos P, Garchon HJ.

J Neuroimmunol. 2009 May 29;210(1-2):120-3. doi: 10.1016/j.jneuroim.2009.02.004. Epub 2009 Mar 10.

PMID:
19278738
9.

Allogeneic hematopoietic SCT for patients with autoimmune diseases.

Daikeler T, Hügle T, Farge D, Andolina M, Gualandi F, Baldomero H, Bocelli-Tyndall C, Brune M, Dalle JH, Urban C, Ehninger G, Gibson B, Linder B, Lioure B, Marmont A, Matthes-Martin S, Nachbaur D, Schuetz P, Tyndall A, van Laar JM, Veys P, Saccardi R, Gratwohl A; Working Party Autoimmune Diseases of the EBMT.

Bone Marrow Transplant. 2009 Jul;44(1):27-33. doi: 10.1038/bmt.2008.424. Epub 2009 Jan 12. Erratum in: Bone Marrow Transplant. 2009 Jul;44(1):67. Urban, C [added].

PMID:
19139739
10.

Why are there regional differences in stem cell transplantation activity? An EBMT analysis.

Gratwohl A, Baldomero H, Frauendorfer K, Niederwieser D; Joint Accreditation Committee of the International Society for Cellular Therapy ISCT; European Group for Blood and Marrow Transplantation EMBT (JACIE).

Bone Marrow Transplant. 2008 Aug;42 Suppl 1:S7-S10. doi: 10.1038/bmt.2008.104.

PMID:
18724308
11.

Haematopoietic stem cell donor registries: World Marrow Donor Association recommendations for evaluation of donor health.

Sacchi N, Costeas P, Hartwell L, Hurley CK, Raffoux C, Rosenmayr A, Greinix H; Quality Assurance and Clinical Working Groups of the World Marrow Donor Association.

Bone Marrow Transplant. 2008 Jul;42(1):9-14. doi: 10.1038/bmt.2008.76. Epub 2008 Mar 24.

PMID:
18362904
12.

HLA Association with hematopoietic stem cell transplantation outcome: the number of mismatches at HLA-A, -B, -C, -DRB1, or -DQB1 is strongly associated with overall survival.

Loiseau P, Busson M, Balere ML, Dormoy A, Bignon JD, Gagne K, Gebuhrer L, Dubois V, Jollet I, Bois M, Perrier P, Masson D, Moine A, Absi L, Reviron D, Lepage V, Tamouza R, Toubert A, Marry E, Chir Z, Jouet JP, Blaise D, Charron D, Raffoux C.

Biol Blood Marrow Transplant. 2007 Aug;13(8):965-74.

13.

[Economic evaluation of the organization of a registry of haematopoietic stem cell donors].

Feve F, Cambon-Thomsen A, Eliaou JF, Gourraud PA, Raffoux C, Florens JP.

Rev Epidemiol Sante Publique. 2007 Aug;55(4):275-84. French.

PMID:
17597327
14.

Relevance of KIR gene matching in unrelated hematopoietic stem cell transplantations.

Gagne K, Busson M, Balere-Appert ML, Absi L, Jollet I, Bignon JD, Bois M, Dormoy A, Dubois V, Gebuhrer L, Loiseau P, Masson D, Moine A, Perrier P, Reviron D, Charron D, Raffoux C; ARS 2000 FRM and FGM group.

Tissue Antigens. 2007 Apr;69 Suppl 1:118-22.

PMID:
17445183
15.

Strategies for new donor typing based on donor HLA type or donor characteristics.

Little AM, Jindra P, Raffoux C.

Tissue Antigens. 2007 Apr;69 Suppl 1:8-9. Review.

PMID:
17445153
16.

World Marrow Donor Association guidelines for use of HLA nomenclature and its validation in the data exchange among hematopoietic stem cell donor registries and cord blood banks.

Bochtler W, Maiers M, Oudshoorn M, Marsh SG, Raffoux C, Mueller C, Hurley CK.

Bone Marrow Transplant. 2007 Jun;39(12):737-41. Epub 2007 Apr 16.

PMID:
17438587
17.

Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Cell Therapy.

Yakoub-Agha I, Mesnil F, Kuentz M, Boiron JM, Ifrah N, Milpied N, Chehata S, Esperou H, Vernant JP, Michallet M, Buzyn A, Gratecos N, Cahn JY, Bourhis JH, Chir Z, Raffoux C, Socié G, Golmard JL, Jouet JP; French Society of Bone Marrow Transplantation and Cell Therapy.

J Clin Oncol. 2006 Dec 20;24(36):5695-702. Epub 2006 Nov 20.

PMID:
17116940
18.

Inferred HLA haplotype information for donors from hematopoietic stem cells donor registries.

Gourraud PA, Lamiraux P, El-Kadhi N, Raffoux C, Cambon-Thomsen A.

Hum Immunol. 2005 May;66(5):563-70. Epub 2005 Mar 3.

PMID:
15935894
19.

Cost-effectiveness analysis of two strategies for typing unrelated donors for bone marrow transplantation in France.

Berchery D, Molinier L, Baouz A, Raffoux C, Cambon-Thomsen A.

Eur J Health Econ. 2003;4(2):130-7.

PMID:
15609180
20.

A special report: suggested procedures for international unrelated donor search from the donor registries and quality assurance working groups of the World Marrow Donor Association (WMDA).

Wiegand T, Raffoux C, Hurley CK, Kern M, Oudshoorn M, Raymond J, Cleaver S, Marry E, Muller C; World Marrow Donor Association Quality Assurance Work Group; WMDA Donor Registries Working Group.

Bone Marrow Transplant. 2004 Jul;34(2):97-101.

PMID:
15170174

Supplemental Content

Loading ...
Support Center